| Biomarkers, atherosclerosis and cardiovascular events. | |
| | |
MedLine Citation:
|
PMID: 18510479 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The 57th Annual Scientific Session of the American College of Cardiology was held in Chicago (IL, USA) between 29 March and 1 April 2008. It was attended by nearly 30,000 participants from around the world. The conference was highlighted by the presentation of 13 late-breaking clinical trials and 13 late-breaking abstracts. |
| | |
Authors:
|
Robert S Rosenson |
Related Documents
:
|
20094329 - Eclipse instrumentation for the solar corona. 1294139 - Docking of dogs: practical and ethical aspects. 19509099 - Endocrine treatment of transsexual persons: an endocrine society clinical practice guid... 21391849 - Institutional profile: the international society for cellular therapy: evolving to meet... 11314609 - Electronic communication in ethics committees: experience and challenges. |
Publication Detail:
|
Type: Clinical Conference; Journal Article; Review |
Journal Detail:
|
Title: Expert review of cardiovascular therapy Volume: 6 ISSN: 1744-8344 ISO Abbreviation: Expert Rev Cardiovasc Ther Publication Date: 2008 Jun |
Date Detail:
|
Created Date: 2008-05-30 Completed Date: 2008-07-16 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101182328 Medline TA: Expert Rev Cardiovasc Ther Country: England |
Other Details:
|
Languages: eng Pagination: 619-22 Citation Subset: IM |
Affiliation:
|
Department of Medicine, University of Michigan, Division of Cardiovascular Medicine, 24 Frank Lloyd Wright Drive, Lobby A, Ann Arbor, MI 48106, USA. rrosenso@umich.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
administration & dosage Antilipemic Agents / administration & dosage Atherosclerosis / diagnosis*, drug therapy*, etiology, mortality Biological Markers / analysis* Cardiovascular Agents / administration & dosage Cardiovascular Diseases / diagnosis*, drug therapy*, etiology, mortality Diabetes Mellitus / diagnosis, drug therapy Drug Therapy, Combination Female Humans Hypercholesterolemia / complications, drug therapy Hypertension / complications, drug therapy Male Prognosis Randomized Controlled Trials as Topic Risk Assessment Sensitivity and Specificity Survival Analysis Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 0/Antilipemic Agents; 0/Biological Markers; 0/Cardiovascular Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Abciximab: a review and update for clinicians.
Next Document: Confusion over thiazolidinedione-induced heart failure: need for a better definition of heart failur...